International Forum of Allergy & Rhinology

Article	Citations
Smell dysfunction: a biomarker for COVID‐19	550
Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms	536
International consensus statement on allergy and rhinology: rhinosinusitis 2021	389
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies	259
Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19	254
Potential pathogenesis of ageusia and anosmia in COVID‐19 patients	190
Use of Google Trends to investigate loss‐of‐smell‒related searches during the COVID‐19 outbreak	175
Review of indoor aerosol generation, transport, and control in the context of COVID‐19	115
A primer on viral‐associated olfactory loss in the era of COVID‐19	95
Smell and taste alterations in COVID‐19: a cross‐sectional analysis of different cohorts	95
Smell and taste symptom‐based predictive model for COVID‐19 diagnosis	88
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant	76
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patients	74
Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)	69
Treatment of post‐viral olfactory dysfunction: an evidence‐based review with recommendations	65
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023	62
Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19)	55
Psychophysical tests reveal impaired olfaction but preserved gustation in COVID‐19 patients	54
International Consensus Statement on Obstructive Sleep Apnea	46
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps	46
International consensus statement on allergy and rhinology: Olfaction	45
Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view	43
Management of odontogenic sinusitis: multidisciplinary consensus statement	42
Skull‐base surgery during the COVID‐19 pandemic: the Italian Skull Base Society recommendations	41
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps	40

International Consensus Statement: Spontaneous Cerebrospinal Fluid Rhinorrhea	39
Diagnosing odontogenic sinusitis: An international multidisciplinary consensus statement	38
A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice	31
Interim analysis of an open‐label randomized controlled trial evaluating nasal irrigations in non‐hospitalized patients with coronavirus disease 2019	30
Volumetric assessment of paranasal sinus opacification on computed tomography can be automated using a convolutional neural network	30
Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease	28
Olfactory dysfunction from acute upper respiratory infections: relationship to season of onset	27
Association of subjective olfactory dysfunction and 12‐item odor identification testing in ambulatory COVID‐19 patients	26
Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps	26
Aerosol or droplet: critical definitions in the COVID‐19 era	25
Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps	25
In vitro safety evaluation of a povidone‐iodine solution applied to human nasal epithelial cells	24
Application of holographic augmented reality for external approaches to the frontal sinus	23
Benefits of biologic therapy administered for asthma on co‐existent chronic rhinosinusitis: A real‐world study	23
Patient‐reported olfactory recovery after SARS‐CoV‐2 infection: A 6‐month follow‐up study	23
Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta‐analysis	23
Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop	23
Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia	23
Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma	22
Olfactory cleft mucus inflammatory proteins in CRS: a case‐control study	22
The taste of the pandemic—contemporary review on the current state of research on gustation in coronavirus disease 2019 (COVID‐19)	21
Asthma increases long‐term revision rates of endoscopic sinus surgery in chronic rhinosinusitis with and without nasal polyposis	21
The association of frailty with olfactory and gustatory dysfunction in older adults: a nationally representative sample	21
Long noncoding RNA MAGI2‐AS3/miR‐218‐5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma	20
Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling	20
Long‐term olfactory dysfunction in COVID‐19 patients: 18‐month follow‐up study	20
Predictors of survival outcomes in sinonasal squamous cell carcinoma: an analysis of the National Cancer Database	20
Cryotherapy for treatment of chronic rhinitis: 3‐month outcomes of a randomized, sham‐controlled trial	20
Comparison of bacterial maxillary sinus cultures between odontogenic sinusitis and chronic rhinosinusitis	20
Making scents of loss of taste in COVID‐19: Is self‐reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing	20
Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps	19
Parosmia in patients with COVID‐19 and olfactory dysfunction	19
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations	19
A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis	19
Suction mitigation of airborne particulate generated during sinonasal drilling and cautery	18
Effects of olfactory training on posttraumatic olfactory dysfunction: a systematic review and meta‐analysis	18
Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis	18
Prophylactic antibiotics after endoscopic sinus surgery for chronic rhinosinusitis: a randomized, double‐blind, placebo‐controlled noninferiority clinical trial	18
International registry of otolaryngologist–head and neck surgeons with COVID‐19	18
Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps	18
Quality‐of‐life impact after in‐office treatment of nasal valve obstruction with a radiofrequency device: 2‐year results from a multicenter, prospective clinical trial	17
Comparison of self‐reported symptoms and psychophysical tests in coronavirus disease 2019 (COVID‐19) subjects experiencing long‐term olfactory dysfunction: a 6‐month follow‐up study	17
Self‐reported olfactory loss in COVID‐19: is it really a favorable prognostic factor?	17
The microbiome of pediatric patients with chronic rhinosinusitis	17
Staphylococcus aureusbiofilm exoproteins are cytotoxic to human nasal epithelial barrier in chronic rhinosinusitis	17
Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps	17
Are patients with chronic rhinosinusitis with nasal polyps at a decreased risk of COVID‐19 infection?	17
Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial	16
Reflections and new developments within the COVID‐19 pandemic	16
Revisiting the controversy: The role of fungi in chronic rhinosinusitis	16

Effects of povidone‐iodine composite on the elimination of bacterial biofilm	16
The predictive utility of the 22‐item sino‐nasal outcome test (SNOT‐22): A scoping review	15
Clinical characteristics and cytokine profiles of central‐compartment‐type chronic rhinosinusitis	15
Exclusively endoscopic endonasal resection of benign orbital tumors: a systematic review and meta‐analysis	15
Impact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis	15
Effectiveness of using a bioabsorbable implant (Latera) to treat nasal valve collapse in patients with nasal obstruction: systemic review and meta‐analysis	15
Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID‐19) patients	15
Exposure to environmental black carbon exacerbates nasal epithelial inflammation via the reactive oxygen species (ROS)–nucleotide‐binding, oligomerization domain–like receptor family, pyrin domain con	14
Machine learning of biomarkers and clinical observation to predict eosinophilic chronic rhinosinusitis: a pilot study	14
At the center of the COVID‐19 pandemic: Lessons learned for otolaryngology‐head and neck surgery in China	14
The role of preoperative blood eosinophil counts in distinguishing chronic rhinosinusitis with nasal polyps phenotypes	14
Major complications of aspirin desensitization and maintenance therapy in aspirin‐exacerbated respiratory disease	13
Randomized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery	13
HPV in the malignant transformation of sinonasal inverted papillomas: A meta‐analysis	13
Solitary chemosensory cells are innervated by trigeminal nerve endings and autoregulated by cholinergic receptors	13
A comparison of central compartment atopic disease and lateral dominant nasal polyps	13
Medical and surgical treatment outcomes in patients with chronic rhinosinusitis and immunodeficiency: a systematic review	13
Central compartment atopic disease: the missing link in the allergy and chronic rhinosinusitis with nasal polyps saga	13
Parosmia assessment with structured questions and its functional impact in patients with long‐term COVID‐19–related olfactory dysfunction	12
Efficacy of the exhalation delivery system with fluticasone in patients who remain symptomatic on standard nasal steroid sprays	12
Divergent bitter and sweet taste perception intensity in chronic rhinosinusitis patients	12
Eustachian tube dysfunction (ETD) in chronic rhinosinusitis with comparison to primary ETD: A systematic review and meta‐analysis	12
Quality‐of‐life instruments in endoscopic endonasal skull base surgery—A practical systematic review	12
Chronic interleukin‐13 expression in mouse olfactory mucosa results in regional aneuronal epithelium	12
Racial and ethnic disparities in paranasal sinus malignancies	12
Feasibility of a deep learning‐based algorithm for automated detection and classification of nasal polyps and inverted papillomas on nasal endoscopic images	12
Olfactory dysfunction after coronavirus disease 2019 (COVID‐19) vaccination	12
Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID‐19) patients	12
Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid use	12
Elevated mucus interleukin‐17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis	12
Odorant metabolism of the olfactory cleft mucus in idiopathic olfactory impairment patients and healthy volunteers	12
Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once‐daily oral antibiotic treatment for chronic rhinosinusitis	11
Endoscopic sinus surgery for chronic rhinosinusitis: 22‐item Sino‐Nasal Outcome Test 5‐year results	11
Differential olfactory outcomes in COVID‐19: A large healthcare system population study	11
Superior turbinate management and olfactory outcome after endoscopic endonasal transsphenoidal surgery for pituitary adenoma: a propensity score‒matched cohort study	11
The management of cystic fibrosis chronic rhinosinusitis: An evidenced‐based review with recommendations	11
Deep learning classification of inverted papilloma malignant transformation using 3D convolutional neural networks and magnetic resonance imaging	11
Systematic review of measures of disease severity in rhinitis	11
Assessment of patient recognition of coronavirus disease 2019 (COVID‐19)‐associated olfactory loss and recovery: a longitudinal study	11
Does phenotypic expression of bitter taste receptor T2R38 show association with COVID‐19 severity?	11
Low‐dose and long‐term azithromycin significantly decreases Staphylococcus aureus in the microbiome of refractory CRS patients	10
Association of cytokine profile with prior treatment failure and revision surgery in chronic rhinosinusitis	10
The clinical effect of psychosomatic interventions on empty nose syndrome secondary to turbinate‐sparing techniques: a prospective self‐controlled study	10
Azithromycin in high‐risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double‐blind, randomized, placebo‐controlled trial	10
Azithromycin and ciprofloxacin inhibit interleukin‐8 secretion without disrupting human sinonasal epithelial integrity in vitro	10
Surgical repair of nasal septal perforations: A systematic review and meta‐analysis	10
Association of spontaneous cerebrospinal fluid rhinorrhea with transverse venous sinus stenosis: a retrospective matched case‐control study	10
Inflammation‐driven vascular dysregulation in chronic rhinosinusitis	10
The management of periorbital cellulitis secondary to sinonasal infection: a multicenter prospective study in the United Kingdom	10
Responsiveness and convergent validity of the chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure in CRS patients undergoing endoscopic sinus surgery	10
Olfactory training: what is the evidence?	10
Psychophysical assessment of olfactory and gustatory function in post‐mild COVID‐19 patients: A matched case‐control study with 2‐year follow‐up	10
Disease control after surgery for chronic rhinosinusitis: prospective, multi‐institutional validation of the Sinus Control Test	10
Interleukin 13 (IL‐13) alters hypoxia‐associated genes and upregulates CD73	9
Relationship between socioeconomic status, exposure to airborne pollutants, and chronic rhinosinusitis disease severity	9
Gender and authorship trends in rhinology, allergy, and skull‐base literature from 2008 to 2018	9
Characterization and implications of the lingual process of the sphenoid bone: a cadaveric and radiographic study	9
Long‐acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study	9
Integrated miRNA and mRNA expression profiling reveals dysregulated miRNA‐mRNA regulatory networks in eosinophilic and non‐eosinophilic chronic rhinosinusitis with nasal polyps	9
Pepsin exposure in a non‐acidic environment upregulates mucin 5AC (MUC5AC) expression via matrix metalloproteinase 9 (MMP9)/nuclear factor κB (NF‐κB) in human airway epithelial cells	9
Endonasal drilling may be employed safely in the COVID‐19 era	9
Understood? Evaluating the readability and understandability of intranasal corticosteroid delivery instructions	9
Trigeminal features in COVID‐19 patients with smell impairment	9
Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups	9
Clinical factors associated with lower health scores in COVID‐19–related persistent olfactory dysfunction	9
Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case‐matched comparison	9
CRS‐PRO and SNOT‐22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis	9
“Black fungus”: a perspective on the coronavirus disease 2019 (COVID‐19)‐associated rhino‐orbital mucormycosis epidemic in India	9
Rhinologic disease and its impact on sleep: a systematic review	9
Targetable pathogenic mechanisms in nasal polyposis	9
Local nasal immunotherapy for allergic rhinitis: A systematic review and meta‐analysis	8
Psychophysical olfactory testing in COVID‐19: is smell function really impaired in nearly all patients?	8
Mental health burden of empty nose syndrome compared to chronic rhinosinusitis and chronic rhinitis	8
Temperature‐controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12‐month outcomes after treatment in a randomized controlled trial	8
Diagnosis, Prognosticators, and Management of Acute Invasive Fungal Rhinosinusitis: Multidisciplinary Consensus Statement and Evidence‐Based Review with Recommendations	8
Temperature‐controlled radiofrequency device treatment of the nasal valve for nasal airway obstruction: A randomized controlled trial	8
In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis	8
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors	8
Deep learning automated segmentation of middle skull‐base structures for enhanced navigation	8
A multicenter real‐life study on the multiple reasons for uncontrolled allergic rhinitis	8

Prospective assessment of smell and taste impairment in a South‐American coronavirus disease 2019 (COVID‐19) cohort: Association with the need for hospitalization and reversibility of dysfunction	8
Outcomes of limited versus extensive surgery for chronic rhinosinusitis: A systematic review and meta‐analysis	8
The association of frailty, age, and ASA classification with postoperative outcomes in endoscopic sinus surgery	8
Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review	8
Long‐term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients	8
Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma	8
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients wit	8
Period2 gene regulates diurnal changes of nasal symptoms in an allergic rhinitis mouse model	8
GPT‐4 accuracy and completeness against International Consensus Statement on Allergy and Rhinology: Rhinosinusitis	8
Systematic review of real‐world persistence and adherence in subcutaneous allergen immunotherapy	8
Preprocedural COVID‐19 screening: Do rhinologic patients carry a unique risk burden for false‐negative results?	7
Predictors of rhinorrhea response after posterior nasal nerve cryoablation for chronic rhinitis	7
Rhinology Medicare reimbursements have not been keeping up with inflation	7
Long‐term outcomes following repair of nasal valve collapse with temperature‐controlled radiofrequency treatment for patients with nasal obstruction	7
Assessing health literacy in rhinologic patients	7
Olfaction before and after initiation of elexacaftor‐tezacaftor‐ivacaftor in a cystic fibrosis cohort	7
Immunotherapy in sinonasal melanoma: treatment patterns and outcomes compared to cutaneous melanoma	7
Impact of omalizumab on pollen‐induced seasonal allergic rhinitis: An observational study in clinical practice	7
Chronic rhinosinusitis could increase the risk of cholesteatoma of middle ear	7
Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia	7
Correlation between middle turbinate insertion in relation to sphenopalatine foramen and failure rates of cryotherapy and radiofrequency treatment for chronic rhinitis	7
Aerosol generation with common rhinologic devices: cadaveric study conducted in a surgical suite	7
Lipopolysaccharide regulates thymic stromal lymphopoietin expression via TLR4/MAPK/Akt/NF‐κB‒signaling pathways in nasal fibroblasts: differential inhibitory effects of macrolide and corticosteroid	7
Adjunctive techniques to dacryocystorhinostomy: an evidence‐based review with recommendations	7
The association of active and passive tobacco smoke exposure with chronic rhinosinusitis symptom severity: A cross‐sectional study	7
Contributing factors for delayed postoperative cerebrospinal fluid leaks and suggested treatment algorithm	7
Acute invasive fungal sinusitis: Epidemiology and outcomes in the United States	7
The cost of rhinitis in the United States: a national insurance claims analysis	7
Association between social determinants of health and olfactory function: a scoping review	7
Lynch vs transcaruncular approach: optimizing access to the lateral frontal sinus	7
Postoperative protocols following endoscopic skull base surgery: An evidence‐based review with recommendations	7
American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery	7
Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization	7
The empty nose syndrome 6‐item questionnaire (ENS6Q): a diagnostic tool to distinguish empty nose syndrome from primary nasal obstruction	6
Cystic fibrosis transmembrane conductance regulator function, not TAS2R38 gene haplotypes, predict sinus surgery in children and young adults with cystic fibrosis	6
The 15° reverse Trendelenburg position can improve visualization without impacting cerebral oxygenation in endoscopic sinus surgery—A prospective, randomized study	6
Nasal cytology in allergic rhinitis: Rare observation of pollen degranulation	6
Hypothalamic‐pituitary‐adrenal axis suppression and intranasal corticosteroid use: A systematic review and meta‐analysis	6
Circadian rhythm disruption exacerbates Th2‐like immune response in murine allergic airway inflammation	6
Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta‐analysis	6
Challenges in interpreting the diagnostic performance of symptoms to predict COVID‐19 status: The case of anosmia	6
Olfactory cleft mucus proteome in chronic rhinosinusitis: a case‐control pilot study	6
Nasal nitric oxide as a long‐term monitoring and prognostic biomarker of mucosal health in chronic rhinosinusitis	6
What is allergic fungal sinusitis: A call to action	6
Determinants of survival in sinonasal and skull base chondrosarcoma: An analysis of the National Cancer Database	6
Machine learning evaluates improvement in sinus computed tomography opacification with CFTR modulator therapy	6
Conjunctivodacryocystorhinostomy (CDCR) success rates and complications in endoscopic vs non‐endoscopic approaches: a systematic review	6
Objective and patient‐based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy	6
Patient‐reported sleep outcomes lack association with mucosal eosinophilia or neutrophilia in patients with chronic rhinosinusitis undergoing functional endoscopic sinus surgery	6
Surgical outcomes in aspirin‐exacerbated respiratory disease without aspirin desensitization	6
Management of chronic rhinosinusitis with steroid nasal irrigations: A viable nonsurgical alternative in the COVID‐19 era	6
Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II	6
An internally validated diagnostic tool for acute invasive fungal sinusitis	6
In vitro evaluation of a novel oxygen‐generating biomaterial for chronic rhinosinusitis therapy	6
Improvement in sinonasal quality‐of‐life indicators for pediatric patients with cystic fibrosis treated with elexacaftor‐tezacaftor‐ivacaftor	6
Quantitative determination of the optimal temporoparietal fascia flap necessary to repair skull‐base defects	6
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps	6
Pulmonary arterial pressure and nasal obstruction in mouth‐breathing children: Similarities between adenotonsillar hypertrophy and allergic rhinitis	6
Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study	6
Influence of facility volume and type on esthesioneuroblastoma treatment and outcomes	5
Clinical characteristics of central compartment atopic disease in Southern China	5
Reply to: Self‐reported olfactory loss in COVID‐19: is it really a favorable prognostic factor?	5
Similarities between allergen sensitivity patterns of central compartment atopic disease and allergic rhinitis	5
The Omicron variant of SARS‐CoV‐2 and its effect on the olfactory system	5
International Registry of Otolaryngologist‒Head and Neck Surgeons with COVID‐19	5
Endoscopic surgery is superior to intensity‐modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma	5
Systematic review of anterior congenital cephaloceles: open vs endoscopic repair	5
Prophylactic and therapeutic topical povidone‐iodine in coronavirus disease 2019 (COVID‐19): What is the evidence?	5
Inflammatory endotype of odontogenic sinusitis	5
Exploring possibilities for shortening the 22‐item Sino‐Nasal Outcome Test (SNOT‐22) using item response theory	5
Specific sublingual immunotherapy in children with perennial rhinitis: a systemic review and meta‐analysis	5
Omalizumab and quality of life in nasal polyps: A post hoc analysis	5
Biologics for chronic rhinosinusitis with nasal polyps: Economics and ethics	5
Characterization of the tumor immune microenvironment of sinonasal squamous‐cell carcinoma	5
Calprotectin in chronic rhinosinusitis eosinophil extracellular traps	5
What do we mean when we have a “sinus infection?”	5
	5
Aspirin desensitization for aspirin‐exacerbated respiratory disease in the era of biologics: Clinical perspective	5
Fungal sinusitis: a spectrum of disease	5
Evaluating inflammation in an obstruction‐based chronic rhinosinusitis model in rabbits	5
Gender‐related differences in outcomes after endoscopic sinus surgery	5
Can we assess the sense of smell through a face mask?	5
Investigation of topical intranasal cocaine for sinonasal procedures: a randomized, phase III clinical trial	5
Heterogeneous distribution of mature olfactory sensory neurons in human olfactory epithelium	5
Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population	5
The digital scent device as a new concept for olfactory assessment	5
Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID‐19) patients: an observational study	5
Effect of the COVID‐19 pandemic on the mental health, daily and occupational activities of otolaryngologists and allergists in Colombia: a national study	5
Private payer‐negotiated prices for FDA‐approved biologic treatments for allergic diseases	5
Taste receptors in chronic rhinosinusitus, what is the evidence? A systematic review	5
Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations	5
An algorithm for sellar reconstruction following endoscopic transsphenoidal surgery for pituitary adenoma: A review of 582 cases	5
Predictive value of clinical characteristics in eosinophilic chronic rhinosinusitis with nasal polyps: A cross‐sectional study in the Chinese population	5
Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta‐analyses	5
Targeted 595‐gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma	4